Regulatory Risk Reduction in the Cloud

2020 will be a big year for the cloud in the life sciences industry. With the large number of companies across all areas — including medical device, pharmaceutical, and biotech — beginning to leverage the power of the cloud, coupled with the upcoming release of the FDA’s Computer Software Assurance (CSA) guidance, there has never been a better time to dive into the rapidly calming waters the cloud offers.
Read more...

;